| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |